Vitamin D analog 25-(OH)-16,23E-diene-26,27-hexafluoro-vitamin D3 induces differentiation of HL60 cells with minimal effects on cellular calcium homeostasis

Journal of Cellular Biochemistry

Volumn 63, Issue 4, 1996, Pages 500-512

  Gardner, Jeffrey P ^a   Zhang, Fan ^a   Uskokovic, Milan R ^b   Studzinski, George P ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b HOFFMANN LA ROCHE INC   (United States)

Author keywords

cell cycle blocks; differentiation; intracellular calcium; store dependent calcium influx; vitamin D3

Indexed keywords

25 HYDROXY 16,23 DIENE 26,26,26,27,27,27 HEXAFLUOROVITAMIN D3; 9,10 SECOCHOLESTA 5,7,10(19),16 TETRAEN 23 YNE 1,3,25 TRIOL; CALCITRIOL; CALCIUM ION; RO 24 2287; RO 25 9887; UNCLASSIFIED DRUG; VITAMIN D DERIVATIVE;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CELL DIFFERENTIATION; CELL STRAIN HL 60; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TRANSPORT KINETICS;

ANTIGENS, CD11; ANTIGENS, CD14; CALCIUM; CELL CYCLE; CELL DIFFERENTIATION; CELLS, CULTURED; CHOLECALCIFEROL; ENZYME INHIBITORS; ETHANOL; FLOW CYTOMETRY; G1 PHASE; G2 PHASE; HUMANS; LEUKEMIA; MANGANESE; MEMBRANE PROTEINS; MOLECULAR STRUCTURE; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; S PHASE; THAPSIGARGIN;

EID: 0030461573     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19961215)63:4<500::AID-JCB11>3.0.CO;2-H     Document Type: Article

References (39)

1. 3. Proc Natl Acad Sci USA 78:4990-4994.
2. 3, inhibits the growth of human breast cancer in vivo and in vitro without causing hypercalcemia. Endocrinology 129:832-837.
3. Abe-Hashimoto J, Kikuchi T, Matsumoto T, Nishii Y, Ogata E, Ikeda K (1993): Antitumor effect of 22-oxa-calcitriol, a noncalcemic analogue of calcitriol, in athymic mice implanted with human breast carcinoma, and its synergism with tamoxifen. Cancer Res 53:2534-2537.
4. Anzano MA, Smith JM, Uskokovic MR, Peer CW, Mullen LT, Letterio JJ, Welsh MC, Shrader MW, Logsdon DL, Driver CL, Brown CC, Roberts AB, Sporn MB (1994): 1α,25-Dihydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol (Ro24-5531), a new deltanoid (vitamin D analogue) for prevention of breast cancer in the rat. Cancer Res 54:1653-1656.
5. Baggiolini EG, Iacobelli JA, Hennessy BM, Batcho AD, Sereno JF, Uskokovic MR (1986): Stereocontrolled total synthesis of 1α,25-dihydroxycholecalciferol and 1α,25-dihydroxyergocalciferol. J Organic Chem 51:3098-3108.
6. Balasubramanyam M, Gardner JP (1995): Protein kinase C modulates cytosolic free calcium by stimulating calcium pump activity in Jurkat T cells. Cell Calcium 18:522-537.
7. Bouillon R, Okamura WH, Norman AW (1995): Structure-function relationships in the vitamin D endocrine system. Endocr Rev 16:200-213.
8. 3. Mol Endocrinol 9:1814-1824.
9. 2+ influx. J Biol Chem 267:2164-2172.
10. Colston KW, Mackay AL, James SY, Binderup L, Chander S, Coombes RC (1992): EB 1089: A new vitamin D analogue that inhibits the growth of breast cancer cells in vivo and vitro. Biochem Pharm 44:2273-2280.
11. 3. Cancer Res 47:21-25.
12. 3. Cell Prolif, 27:37-46.
13. Griffin JD, Ritz J, Nadler LM, Schlossman SF (1981): Expression of myeloid differentiation antigens on normal and malignant myeloid cells. J Clin Invest 68:933-941.
14. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260:3440-3450.
15. Hallam F, Rink TJ (1985): Agonists stimulate divalent cation channels in the plasma membrane of human platelets. FEBS Lett 186:175-179.
16. 3, MC-903, and their analogues herald a new pharmacologic era for the treatment of psoriasis. Arch Dermatol 125:1692-1697.
17. 3 metabolically active in the intestine. Proc Natl Acad Sci USA 68:803-804.
18. 3 prolong survival time of mice inoculated with myeloid leukemia cells. Cell Biol 80:201-204.
19. 2+ priming during vitamin D-induced monocytic differentiation of a human leukemia cell line. J Biol Chem 263:16039-16044.
20. 3 is a potent antileukemic agent with low potential to cause hypercalcemia. Leuk Res 18:453-463.
21. 3: In vivo and in vitro effects on human preleukemic and leukemic cells. Cancer Treat Rep 69:1399-1407.
22. Lawson DEM, Fraser DR, Kodicek E, Morris HR, Williams DH (1971): Identification of 1,25-dihydroxycholecalciferol, a new kidney hormone controlling calcium metabolism. Nature 230:228-230.
23. Lucia MS, Anzano MA, Slayter MV, Anver MR, Green DM, Shrader MW, Logsdon DL, Driver CL, Brown CC, Peer CW, Roberts AB, Sporn MB (1995): Chemopreventive activity of tamoxifen, N-(4-hydroxyphenyl)retinamide, and the vitamin D analogue Ro24-5531 for androgen promoted carcinomas of the rat seminal vesicle and prostate. Cancer Res 55:5621-5627.
24. 2+ pumps. J Biol Chem 266:17067-17071.
25. 3 induced differentiation in a human promyelocytic leukemia cell line HL60: Receptor-mediated maturation to macrophage-like cells. J Cell Biol 98:391-398.
26. Myrtle J, Haussler MR, Norman AW (1970): Evidence for the biologically active form of cholecalciferol in the intestine. J Biol Chem 245:1190-1196.
27. Norman AW (1979): "Vitamin D: The Calcium Homeostatic Steroid Hormone." New York: Academic Press, pp 1-490.
28. 3, a potent angiogenesis inhibitor, on rat mammary tumors induced by 7,12-dimethylbenz(a)anthracene. Anticancer Drugs 2:475-480.
29. Putney JW, Jr (1991): The capacitative model for receptor-activated calcium entry. Adv Pharmacol 22:251-269.
30. 3 receptors and actions in human prostate cancer cell lines. Endocrinology 132:1952-1960.
31. Studzinski GP, Gierthy JF, Cholon JJ (1973): An autoradiographic screening test for mycoplasmal contamination of mammalian cell cultures. In Vitro 8:466-472.
32. Studzinski GP, Bhandal AK, Brelvi, ZS (1985): A system for monocytic differentiation of leukemic cells HL 60 by 1,25-dihydroxycholecalciferol. Proc Soc Exp Biol Med 179:288-295.
33. 3 of cytotoxicity to HL 60 cells produced by cytarabine and hydroxyurea. J Natl Cancer Inst 76:641-648.
34. Studzinski GP, McLane JA, Uskokovic MR (1993): Signaling pathways for vitamin D-induced differentiation; implications for therapy of proliferative and neoplastic diseases. Crit Rev Eukaryotic Gene Exp 4:229-254.
35. 3. Exp Cell Res 224:312-322.
36. 3 in HL60 cells. Cancer Research, 56:264-267.
37. Wright SD, Ramos RA, Tobias S, Ulvitch J, Mathison JC (1991): CD14, a receptor for complex of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431-1433.
38. 0 phase cell cycle block. Cell Prolif 27:643-654.
39. 3 prolongs survival time of leukemic mice. Proc Natl Acad Sci USA 87:3929-3932.